Match tier Confirmed
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-08-15

Anil K. Patri

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Research Scholar

Also affiliated: Karnatak University (2025); University of Akron (2004); Northwestern University (2010); University of North Carolina at Chapel Hill (2012–2021); Leidos (United States) (2013–2016); National Institutes of Health (2008); United States Food and Drug Administration (2018–2024); NewYork–Presbyterian Hospital (2004); Cornell University (2004); University of South Florida (1997–2004); University of Michigan (2002–2007); New York Hospital Queens (2004); Presbyterian Hospital (2004); Southwestern Medical Center (2010); Michigan Medicine (2005); Lubrizol Life Science Health (United States) (2012); Frederick National Laboratory for Cancer Research (2010–2016); National Cancer Institute (2006–2013); Food and Drug Administration (2018–2021); Robert H. Lurie Comprehensive Cancer Center of Northwestern University (2010); Leidos Biomedical Research Inc. (United States) (2014); The University of Texas Southwestern Medical Center (2010); Science Applications International Corporation (United States) (2006–2023); Texas A&M University (2010)

Faculty Researcher

40 h-index 103 pubs 12,114 cited

  • Humans
  • Animals
  • Nanoparticles
  • Dendrimers
  • Drug Delivery Systems
  • Particle Size
  • Nanomedicine
  • Mice
  • Metal Nanoparticles
  • Gold
  • Drug Carriers
  • Female
  • Neoplasms
  • Nanostructures
  • Cell Line, Tumor

Biography and Research Information

OverviewAI-generated summary

Anil K. Patri's research focuses on the regulatory science and toxicological assessment of emerging technologies, particularly nanotechnology and nanoplastics. His work investigates the impact of these materials on human and animal systems, with a specific emphasis on their detection, characterization, and potential health effects.

Recent publications from Patri and his collaborators explore the regulatory landscape of nanotechnology and nanoplastics from a global perspective, as well as the impact of emerging technologies on regulatory science. His research includes the comprehensive analysis of common polymers for the identification and quantitation of micro- and nanoplastics in food and human cells. He has also investigated the biodistribution and toxic potential of silver nanoparticles in the female rat reproductive tract and the alteration of DNA methylation in human cells following exposure to titanium dioxide products. Further research includes the optimization of detection methods for gadodiamide brain retention in rats using quantitative T2 mapping.

Patri leads a research group and maintains an active lab website. His scholarship metrics include an h-index of 40, 103 total publications, and 11,992 total citations, designating him as a highly cited researcher.

Metrics

  • h-index: 40
  • Publications: 103
  • Citations: 12,114

Selected Publications

  • Evaluation of sources of variability in a nitric oxide screening assay for engineered nanomaterials (2025)
    Nanomedicine Nanotechnology Biology and Medicine DOI OpenAlex
  • Exposure to a Titanium Dioxide Product Alters DNA Methylation in Human Cells (2024)
    Nanomaterials 2 citations DOI OpenAlex
  • Biodistribution and toxic potential of silver nanoparticles when introduced to the female rat reproductive tract (2024)
    NanoImpact 4 citations DOI OpenAlex
  • Regulatory Science Perspective on the Analysis of Microplastics and Nanoplastics in Human Food (2024)
    Analytical Chemistry 43 citations DOI OpenAlex
  • Comprehensive analysis of common polymers using hyphenated TGA-FTIR-GC/MS and Raman spectroscopy towards a database for micro- and nanoplastics identification, characterization, and quantitation (2023)
    NanoImpact 44 citations DOI OpenAlex
  • Nanotechnology in vaccines and personalized medicine (2023)
    Elsevier eBooks 1 citation DOI OpenAlex
  • Radiation impacts on toxicity of cobalt–chromium (CoCr) implant debris (2023)
    Nanotoxicology 1 citation DOI OpenAlex
  • Optimization of Detection of Gadodiamide Brain Retention in Rats Using Quantitative <scp>T<sub>2</sub></scp> Mapping and Intraperitoneal Administration (2022)
    Journal of Magnetic Resonance Imaging 2 citations DOI OpenAlex
  • Regulatory landscape of nanotechnology and nanoplastics from a global perspective (2021)
    Regulatory Toxicology and Pharmacology 434 citations DOI OpenAlex
  • Sierpiński Pyramids by Molecular Entanglement (2020)
    Journal of the American Chemical Society 18 citations DOI OpenAlex
  • Effect of titanium dioxide nanoparticles on DNA methylation in multiple human cell lines (2020)
    Nanotoxicology 94 citations DOI OpenAlex
  • <i>In Vitro</i> Skin Penetration of Dendrimer Nanoparticles (2019)
    Applied In Vitro Toxicology 12 citations DOI OpenAlex
  • Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Physicochemical Characterization (2018)
    Nanomaterials 24 citations DOI OpenAlex
  • Investigating the Susceptibility of Mice to a Bacterial Challenge After Intravenous Exposure to Durable Nanoparticles (2017)
    Nanomedicine 2 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

50 Collaborators 11 Institutions 5 Countries

Top Collaborators

View profile →
View profile →

Similar Researchers

Based on overlapping research topics